Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions

被引:111
作者
Guengerich, F. Peter [1 ]
机构
[1] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
ARYL-HYDROCARBON HYDROXYLASE; PRIMARY CONGENITAL GLAUCOMA; RESISTANT PROSTATE-CANCER; P-GLYCOPROTEIN; LIVER-MICROSOMES; ADRENAL STEROIDOGENESIS; METABOLIC-ACTIVATION; CHOLESTEROL TURNOVER; IN-VITRO; PHENETHYL ISOTHIOCYANATE;
D O I
10.1021/acs.chemrestox.6b00226
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Today much is known about cytochrome P450 (P450) enzymes and their catalytic specificity, but the range of reactions catalyzed by each still continues to surprise. Historically, P450s had been considered to be involved in either the metabolism of xenobiotics or endogenous chemicals, in the former case playing a generally protective role and in the latter case a defined physiological role. However, the line of demarcation is sometimes blurred. It is difficult to be completely specific in drug design, and some P450s involved in the metabolism of steroids and vitamins can be off-targets. In a number of cases, drugs have been developed that act on some of those P450s as primary targets, e.g., steroid aromatase inhibitors. Several of the P450s involved in the metabolism of endogenous substrates are less specific than once thought and oxidize several related structures. Some of the P450s that primarily oxidize endogenous chemicals have been shown to oxidize xenobiotic chemicals, even in a bioactivation mode.
引用
收藏
页码:2 / 12
页数:11
相关论文
共 104 条
[1]   Cytochrome P450 metabolism of the post-lanosterol intermediates explains enigmas of cholesterol synthesis [J].
Acimovic, Jure ;
Goyal, Sandeep ;
Kosir, Rok ;
Golicnik, Marko ;
Perse, Martina ;
Belic, Ales ;
Urlep, Ziga ;
Guengerich, F. Peter ;
Rozman, Damjana .
SCIENTIFIC REPORTS, 2016, 6
[2]   Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity [J].
Anderson, Kyle W. ;
Mast, Natalia ;
Hudgens, Jeffrey W. ;
Lin, Joseph B. ;
Turko, Illarion V. ;
Pikuleva, Irina A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (22) :11876-11886
[3]  
Auchus R.J., 2015, Cytochrome P450: Structure, Mechanism, and Biochemistry, VII, P851
[4]  
AXELROD JULIUS, 1955, JOUR BIOL CHEM, V214, P753
[5]  
Björkhem I, 2001, J LIPID RES, V42, P366
[6]   Toxicology Strategies for Drug Discovery: Present and Future [J].
Blomme, Eric A. G. ;
Will, Yvonne .
CHEMICAL RESEARCH IN TOXICOLOGY, 2016, 29 (04) :473-504
[7]  
BOLT HM, 1977, ACTA ENDOCRINOL-COP, V85, P189
[8]   METABOLIC-ACTIVATION AND BINDING OF MITOTANE IN ADRENAL-CORTEX HOMOGENATES [J].
CAI, W ;
COUNSELL, RE ;
DJANEGARA, T ;
SCHTEINGART, DE ;
SINSHEIMER, JE ;
WOTRING, LL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (02) :134-138
[9]   Aromatase, aromatase inhibitors, and breast cancer [J].
Chumsri, Saranya ;
Howes, Timothy ;
Bao, Ting ;
Sabnis, Gauri ;
Brodie, Angela .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2011, 125 (1-2) :13-22
[10]  
Chun YJ, 2001, CANCER RES, V61, P8164